Lithium technology has ushered in a new era of batteries with exceptionally high energy density for a reasonably low cost.

BMS is paying $62.50 per share in cash for San Diego-based RayzeBio and its pipeline of radiopharmaceuticals for solid tumours – including a late-stage candidate for neuroendocrine tumours (NETs ...

Renesas plans to include turn-key R-BMS F solutions in all future FGICs. The R-BMS F for 2 to 4S cell (~8V to 16V) solutions targets small vacuum cleaners, robotic vacuums, consumer and medical ...